ArticleScientific reports2025
Immunoendocrine network under conditions of diabetes-filariasis co-morbidity DMLF6.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Childhood exposure to filariasis can confer significant protection against diabetes which is called as "Metabolic Hygiene Hypothesis". However, the effect of diabetes on anti-filarial immunity is not much studied. In the present study, the role of diabetes on systemic anti-filarial immunity was elucidated. Plasma levels of innate immune cytokines, adaptive immune cytokines, chemokines, hormones and growth factors were quantified by ELISA; Lipid and protein peroxidation and nitrite levels were quantified by spectrophotometry; Peripheral Tregs and exhausted T-cells were quantified by flowcytometry; FoxP3 expression was quantified by qRT-PCR. Anti-filarial immunity was significantly associated with elevated levels of TNF-α, IL-6, IL-1β, IL-10, IL-1Ra, DEF-A1, IL-12, IFN-γ, IL-2, IL-33, IL-9, IL-23, IL-17, IL-8, IP-10, SDF-1, MCP-1 and RANTES and decreased levels of IL-27, IL-4, leptin and FGF-21. Lipid peroxidation, nitrite levels and exhausted T cells were also increased. Chronic diabetes significantly reduced IL-1β, IL-1Ra, DEF-A1 and IL-8 and lipid peroxidation, and increased VEGF levels in DM-LF group. Overall, diabetes was found to downregulate a few critical innate immune components, of anti-filarial immunity, that can promote chronic pathology in LF + subjects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.